• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤和黏膜利什曼病。

Cutaneous and mucocutaneous leishmaniasis.

机构信息

Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Infect Dis Clin North Am. 2012 Jun;26(2):293-307. doi: 10.1016/j.idc.2012.03.001. Epub 2012 Apr 17.

DOI:10.1016/j.idc.2012.03.001
PMID:22632640
Abstract

Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated, or diffuse in distribution and may differ in Old and New World leishmaniases. Diagnosis and treatment vary according to the clinical manifestations, geographic area, and Leishmania species involved. This article highlights the diversity and complexity of tegumentary leishmaniases, which are worsened by human immunodeficiency virus/Leishmania coinfection.

摘要

皮肤利什曼病是由大约 15 种利什曼原虫引起的。它们流行于旧世界和新世界的热带和亚热带地区,但人类的流动性也使它们成为非流行地区的一个医学问题。临床表现可能包括皮肤和黏膜形式,可能局限、扩散或弥漫分布,在旧世界和新世界利什曼病中可能有所不同。诊断和治疗因临床表现、地理区域和涉及的利什曼原虫种类而异。本文重点介绍了皮肤利什曼病的多样性和复杂性,人类免疫缺陷病毒/利什曼原虫合并感染使其更加恶化。

相似文献

1
Cutaneous and mucocutaneous leishmaniasis.皮肤和黏膜利什曼病。
Infect Dis Clin North Am. 2012 Jun;26(2):293-307. doi: 10.1016/j.idc.2012.03.001. Epub 2012 Apr 17.
2
Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.皮肤和黏膜利什曼病的当前诊断和治疗。
Expert Rev Anti Infect Ther. 2010 Apr;8(4):419-33. doi: 10.1586/eri.10.19.
3
[Cutaneous leishmaniasis].[皮肤利什曼病]
Hautarzt. 2008 Aug;59(8):627-32. doi: 10.1007/s00105-008-1598-8.
4
Cutaneous leishmaniasis in the returning traveler.归国旅行者中的皮肤利什曼病
Infect Dis Clin North Am. 2005 Mar;19(1):241-66, x-xi. doi: 10.1016/j.idc.2004.11.005.
5
Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management.皮肤和黏膜利什曼病:鉴别诊断、诊断、组织病理学和治疗。
J Am Acad Dermatol. 2015 Dec;73(6):911-26; 927-8. doi: 10.1016/j.jaad.2014.09.014.
6
Cutaneous and mucocutaneous leishmaniasis.皮肤和黏膜利什曼病。
Dermatol Ther. 2009 Nov-Dec;22(6):491-502. doi: 10.1111/j.1529-8019.2009.01272.x.
7
[Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy].[皮肤利什曼病作为旅行者疾病。临床表现、诊断与治疗]
Hautarzt. 2012 Mar;63(3):233-46; quiz 247-8. doi: 10.1007/s00105-012-2327-x.
8
[Leishmaniasis].[利什曼病]
Ugeskr Laeger. 2000 Nov 13;162(46):6203-7.
9
New World and Old World Leishmania Infections: A Practical Review.新旧世界利什曼原虫感染:实用综述
Dermatol Clin. 2015 Jul;33(3):579-93. doi: 10.1016/j.det.2015.03.018.
10
Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.由圭亚那利什曼原虫引起的播散性皮肤利什曼病:一例有425处皮损患者的病例
Am J Trop Med Hyg. 2004 Nov;71(5):558-60.

引用本文的文献

1
Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10 T cell response.小鼠黏膜利什曼病模型显示出高寄生虫载量、细胞毒性增加和白细胞介素-10 T细胞反应受损。
Front Immunol. 2025 Aug 4;16:1621781. doi: 10.3389/fimmu.2025.1621781. eCollection 2025.
2
Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations.通过体外和计算机模拟研究建立THTT衍生物作为潜在抗利什曼原虫和抗炎剂的研究。
Sci Rep. 2025 Aug 2;15(1):28246. doi: 10.1038/s41598-025-12084-6.
3
Health-related quality of life in Brazilian patients with cutaneous leishmaniasis using EQ-5D.
使用EQ-5D评估巴西皮肤利什曼病患者的健康相关生活质量。
PLoS One. 2025 May 23;20(5):e0324788. doi: 10.1371/journal.pone.0324788. eCollection 2025.
4
Single-nucleotide polymorphisms in genes associated with the vitamin D pathway related to clinical and therapeutic outcomes of American tegumentary leishmaniasis.与维生素D途径相关的基因中的单核苷酸多态性与美洲皮肤利什曼病的临床和治疗结果相关。
Front Cell Infect Microbiol. 2025 Jan 8;14:1487255. doi: 10.3389/fcimb.2024.1487255. eCollection 2024.
5
reduces parasite load and modulates cytokines in BALB/c mice infected with (Leishmania) .降低感染(利什曼原虫)的BALB/c小鼠体内的寄生虫负荷并调节细胞因子。
Front Chem. 2024 Oct 31;12:1492770. doi: 10.3389/fchem.2024.1492770. eCollection 2024.
6
Prevalence of Leishmaniasis among Blood Donors: A Systematic Review and Meta-Analysis.献血者中利什曼病的患病率:系统评价与荟萃分析
Diseases. 2024 Jul 17;12(7):160. doi: 10.3390/diseases12070160.
7
Automated Identification of Cutaneous Leishmaniasis Lesions Using Deep-Learning-Based Artificial Intelligence.使用基于深度学习的人工智能自动识别皮肤利什曼病病变
Biomedicines. 2023 Dec 20;12(1):12. doi: 10.3390/biomedicines12010012.
8
Case Report: Diffuse Cutaneous Leishmaniasis Successfully Treated with a Combination of Oral Rifampicin and Fluconazole.病例报告:口服利福平联合氟康唑成功治疗弥漫性皮肤利什曼病。
Am J Trop Med Hyg. 2023 Jul 10;109(2):315-318. doi: 10.4269/ajtmh.23-0170. Print 2023 Aug 2.
9
Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs.原生动物表观遗传靶点及其抑制剂在新型潜在药物开发中的研究进展
Pharmaceuticals (Basel). 2023 Apr 4;16(4):543. doi: 10.3390/ph16040543.
10
Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer.模仿直肠癌的非典型皮肤黏膜利什曼病表现
Case Rep Infect Dis. 2023 Apr 15;2023:2768626. doi: 10.1155/2023/2768626. eCollection 2023.